cs.CVOct 23, 2026

EigenGradCAM with AugSmooth: Enhancing Explainability and Precision in Multi-Stage Alzheimer's Disease Detection

Authors: Arsham Azam, Sagar Ashraf, Tayyaba Farhat, Rasikh Ali, Sheeraz Akram

Organizations: Faculty of Computer Science and Information Technology, The Superior University, Lahore 54600, Pakistan · Intelligent Data Visual Computing Research (IDVCR), Lahore 54600, Pakistan · HospiceMD, Inc., West Covina, California, USA · Information Systems Department, College of Computer and Information Sciences, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 12571, Saudi Arabia

Abstract

Alzheimer's disease (AD) is a progressive neurological disorder associated with memory loss, cognitive decline, and behavioral disturbances. Early and accurate diagnosis is essential, yet MRI-based deep learning models often lack interpretability, limiting their clinical use. This study presents an explainable deep learning approach for four-class AD staging using 2D axial MRI images. The method combines eigenvector-based Grad-CAM with gradient smoothing to improve saliency localization and heatmap stability. Principal component analysis is applied to gradient-weighted convolutional layers, while Gaussian noise is added to saliency weights before decomposition. To address class imbalance in the Moderate Dementia category, Wasserstein Generative Adversarial Network with Gradient Penalty (WGAN-GP) generates synthetic samples to balance the four-stage training distribution. Custom convolutional neural networks are trained on the Best Alzheimer MRI Dataset, achieving 97.2% test accuracy, 97.0% balanced accuracy, and a Matthews correlation coefficient of 0.944. The area under the ROC curve ranges from 0.96 to 0.99 across classes. Generated heatmaps highlight the hippocampus and entorhinal cortex, regions associated with Alzheimer's disease biomarkers. These findings suggest that the proposed approach combines strong classification performance with improved model interpretability, although further clinical validation is needed.

Explore similar work

Oct 24, 2026

How Robust Are CNNs and Vision Transformers for Alzheimer's MRI Classification Across Datasets?

Accurate assessment of Alzheimer's disease stages from MRI is important for understanding disease progression and supporting the development of computer-aided analysis tools. Deep learning models have shown promising results for Alzheimer's disease classification from MRI. However, when evaluated on single datasets, it is difficult to determine whether the observed performance reflects consistent architectural behavior or dataset-specific effects. In this work, we present a multi-dataset benchmarking framework with standardized preprocessing and evaluation. We compare five architectures: ResNet-50, ReXNet-150, Swin Transformer, ViT-Base, and ViT-Large. The models are evaluated across three MRI datasets representing severe class imbalance, train-test distribution mismatch, and large-scale augmentation. The results show broadly consistent performance patterns across datasets, with ViT-Large achieving the best performance on all three datasets and reaching up to 99.84% accuracy and 99.86% macro F1. Performance differences between architectures are most pronounced under distribution mismatch and considerably smaller in the augmented-data setting. Across datasets, lower class-level performance is observed primarily among adjacent early-stage categories, particularly Very Mild and Mild impairment. These findings highlight the importance of evaluating deep learning architectures across multiple data conditions rather than relying on single-dataset performance.
Sep 11, 2026

A Multimodal Explainable Deep Learning Framework for Alzheimer's Disease Diagnosis using 3D Magnetic Resonance Imaging and Clinical Data

Dementia is a major and growing global health burden, with Alzheimer's disease (AD) accounting for most cases. Timely and accurate diagnosis is central to managing this burden and increasingly depends on integrating complementary clinical and imaging information. Multimodal deep learning can combine these modalities for AD diagnosis, but how its explanations behave across modalities, fusion strategies, and cohorts remains unclear. We developed an explainable multimodal framework pairing a 3D CNN encoder for T1-weighted MRI with a feedforward network for harmonized clinical and demographic data, comparing varied model setups on three-way and pairwise diagnostic tasks using 6,479 internal records from the ADNI and 1,703 independent records from the OASIS-3. On ADNI, the tabular-only model achieved the highest three-class AUC-ROC of 0.879 and best discriminated cognitively normal (CN) versus mild cognitive impairment (MCI; 0.903), while cross-attention performed best for MCI versus AD (0.861); CN versus AD was highly discriminative overall. On OASIS-3, the vision-only model performed best (three-class AUC-ROC 0.910); CN versus MCI remained difficult, and no fusion strategy consistently outperformed single modalities across tasks and cohorts. SHAP and Integrated Gradients identified the MMSE as the dominant tabular feature in both cohorts, with global feature rankings agreeing strongly in ADNI (ρ=0.94ρ=0.94) and OASIS-3 (ρ=0.96ρ=0.96); CAM-based explanations, however, changed with model configuration and cohort. These findings show that multimodal performance and explanations are task, modality, fusion, and cohort-dependent: a dominant cognitive signal persisted across cohorts, but feature contributions and CAM explanations did not, underscoring the need to evaluate explainability under cohort shift rather than as a stable, intrinsic property.
Jun 18, 2026

Alzheimer's Disease Diagnosis using a Multimodal Approach with 3D MRI and PET

Alzheimer's disease (AD) is an irreversible neurodegenerative disorder and a leading cause of death worldwide. Early diagnosis plays an important part especially at the Mild Cognitive Impairment stage, where timely intervention can help slow its progression before it advances to AD. Neuroimaging data, like Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) scans, can help detect brain changes early by providing structural and functional brain changes related to the disease. Yet, many multimodal models still fuse MRI and PET with static concatenation and apply identical computation to all subjects, which limits robustness to patient/site heterogeneity and can waste computation. To address these limitations, we present the first study of combining 3D convolutional feature extractors with three fusion strategies - concatenation, Gated Multimodal Unit (GMU), and gated self-attention - and a sparsely gated Mixture-of-Experts (MoE) classifier that performs input-adaptive routing, activating only the most informative experts per case. Finally, we utilize Grad-CAM to visualize disease-related regions, ensuring model interpretability. Experiments are performed across three binary classification tasks (NC vs. MCI, MCI vs. AD, and NC vs. AD). Results show that GMU achieves accuracies of 80.46 % (NC vs. MCI) and 95.47 % (NC vs. AD), while gated self-attention attains 82.08 % on MCI vs. AD. Ablations show that removing the MoE consistently degrades accuracy across all tasks. These findings underscore the value of input-adaptive, multimodal modeling for AD diagnosis by leveraging the complementary nature of MRI and PET.